Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma

Table 2 NAT1 genotype frequency.

*NAT1*Genotype	Sporadic-CRC		IBD benign		IBD dysplasia/cancer		Control
	No.	%	No.	%	No.	%	No.	%
NAT14/4	73	59.35	205	55.7	9	60	131	58.75
NAT14/10	28	22.77	104	28.3	6	40	61	27.35
NAT110/10	9	7.32	18	4.89			9	4.03
NAT14/14A or 10/14B	4	3.25	13	3.53			7	3.14
NAT14/11B	0	0	6	1.63			5	2.24
NAT14/14B	2	1.63	3	0.81			2	0.9
NAT110/11B	1	0.81	2	0.54			2	0.9
NAT14/3	2	1.63	3	0.81			1	0.45
NAT14/15	0	0	1	0.27			1	0.45
NAT14/11A or 3/11B	1	0.81	0	0			1	0.45
NAT13/11A	0	0	0	0			1	0.45
NAT110/15	0	0	0	0			1	0.45
NAT14/17	0	0	6	1.63			1	0.44
NAT13/3	1	0.81	2	0.54			0	0
NAT110/17	0	0	2	0.54			0	0
NAT110/22	1	0.81	1	0.27			0	0
NAT14/22	0	0	1	0.27			0	0
NAT13/14A	1	0.81	0	0			0	0
NAT14A/*22	0	0	1	0.27			0	0
Total	123		368		15		223

ISSN: 1471-2350